OC-0332: Recurrence patterns and outcomes of dose escalation SBRT for pancreatic cancer: A multicenter study

Radiotherapy and Oncology ◽

10.1016/s0167-8140(21)00356-x ◽

2020 ◽

Vol 152 ◽

pp. S175

Keyword(s):

Pancreatic Cancer ◽

Multicenter Study ◽

Dose Escalation ◽

Recurrence Patterns

Download Full-text

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study

Annals of Oncology ◽

10.1093/annonc/mdl081 ◽

2006 ◽

Vol 17 (7) ◽

pp. 1096-1102 ◽

Author(s):

D.A. Richards ◽

K.A. Boehm ◽

D.M. Waterhouse ◽

D.J. Wagener ◽

S.S. Krishnamurthi ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Multicenter Study ◽

Advanced Pancreatic Cancer ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Gemcitabine plus nab-paclitaxel in older patients with metastatic pancreatic cancer: A post-hoc analysis of the real-world data of a multicenter study (the NAPOLEON study)

Journal of Geriatric Oncology ◽

10.1016/j.jgo.2021.06.011 ◽

2021 ◽

Author(s):

Futa Koga ◽

Yasunori Kawaguchi ◽

Mototsugu Shimokawa ◽

Kenichiro Murayama ◽

Shunya Nakashita ◽

...

Keyword(s):

Pancreatic Cancer ◽

Multicenter Study ◽

Older Patients ◽

Metastatic Pancreatic Cancer ◽

Real World Data ◽

The Real ◽

Post Hoc Analysis ◽

Download Full-text

Safety and tolerability of the first-in-class agent CPI-613 in combination with modified FOLFIRINOX in patients with metastatic pancreatic cancer: a single-centre, open-label, dose-escalation, phase 1 trial

The Lancet Oncology ◽

10.1016/s1470-2045(17)30314-5 ◽

2017 ◽

Vol 18 (6) ◽

pp. 770-778 ◽

Author(s):

Angela Alistar ◽

Bonny B Morris ◽

Rodwige Desnoyer ◽

Heidi D Klepin ◽

Keyanoosh Hosseinzadeh ◽

...

Keyword(s):

Pancreatic Cancer ◽

Dose Escalation ◽

Phase 1 ◽

Metastatic Pancreatic Cancer ◽

Single Centre ◽

Phase 1 Trial ◽

Download Full-text

Real-world fusion landscape in advanced Chinese pancreatic cancer using next generation sequecing: A multicenter study

Annals of Oncology ◽

10.1093/annonc/mdz431.009 ◽

2019 ◽

Vol 30 ◽

pp. ix125-ix126

Author(s):

Y. Shen ◽

S. Fang ◽

X. Cai ◽

Y. Fang ◽

R. Lin ◽

...

Keyword(s):

Pancreatic Cancer ◽

Multicenter Study ◽

Next Generation

Download Full-text

Chernotherapie, nicht jedoch Radiotherapie verbessert die Prognose des resezierten Pankreaskarzinoms: Ergebnisse einer prospektiven randomisierten Multizenterstudie (ESPAC-1) / Chemotherapy — Not Radiotherapy — Improves the Prognosis of Resected Pancreatic Cancer: Results of a Prospective Randomized Multicenter Study (ESPAC-1)

Deutsche Gesellschaft für Chirurgie - Panta Rhei — Umdenken — ◽

10.1007/978-3-642-56458-1_38 ◽

2001 ◽

pp. 126-127

Author(s):

H. Friess ◽

H. G. Beger ◽

J. Neoptolemos ◽

C. Bassi ◽

L. Fernandez-Cruz ◽

...

Keyword(s):

Pancreatic Cancer ◽

Multicenter Study

Download Full-text

Oncologic Impact of Local Recurrence in Resected Pancreatic Cancer and Topographic Preference in Local Recurrence Patterns According to Tumor Location

Pancreas ◽

10.1097/mpa.0000000000001679 ◽

2020 ◽

Vol 49 (10) ◽

pp. 1290-1296

Author(s):

Sung Hoon Choi ◽

Ha Yan Kim ◽

Ho Kyoung Hwang ◽

Chang Moo Kang ◽

Woo Jung Lee

Keyword(s):

Pancreatic Cancer ◽

Local Recurrence ◽

Tumor Location ◽

Recurrence Patterns

Download Full-text

Three fluoropyrimidine-based regimens in routine clinical practice after nab-paclitaxel plus gemcitabine for metastatic pancreatic cancer: An AGEO multicenter study

Clinics and Research in Hepatology and Gastroenterology ◽

10.1016/j.clinre.2019.08.009 ◽

2020 ◽

Vol 44 (3) ◽

pp. 295-301 ◽

Author(s):

Anne-Laure Pointet ◽

David Tougeron ◽

Simon Pernot ◽

Astrid Pozet ◽

Dominique Béchade ◽

...

Keyword(s):

Pancreatic Cancer ◽

Clinical Practice ◽

Multicenter Study ◽

Routine Clinical Practice ◽

Metastatic Pancreatic Cancer

Download Full-text

Intratumoral heterogeneity of SMAD4 immunohistochemical (IHC) expression and its role in prediction of recurrence patterns in patients with resectable pancreatic cancer (PC)

Annals of Oncology ◽

10.1093/annonc/mdx369.112 ◽

2017 ◽

Vol 28 ◽

pp. v248

Author(s):

I. Pokataev ◽

A. Kudaibergenova ◽

A. Artemyeva ◽

D. Podluzhnyi ◽

N. Kudashkin ◽

...

Keyword(s):

Pancreatic Cancer ◽

Intratumoral Heterogeneity ◽

Resectable Pancreatic Cancer ◽

Recurrence Patterns

Download Full-text

A phase 1b dose escalation study of Wnt pathway inhibitor vantictumab in combination with nab-paclitaxel and gemcitabine in patients with previously untreated metastatic pancreatic cancer

Investigational New Drugs ◽

10.1007/s10637-019-00824-1 ◽

2019 ◽

Vol 38 (3) ◽

pp. 821-830 ◽

Author(s):

S. Lindsey Davis ◽

Dana B. Cardin ◽

Safi Shahda ◽

Heinz-Josef Lenz ◽

Efrat Dotan ◽

...

Keyword(s):

Pancreatic Cancer ◽

Dose Escalation ◽

Wnt Pathway ◽

Metastatic Pancreatic Cancer ◽

Dose Escalation Study ◽

Download Full-text

Long-term results and recurrence patterns from SCALOP: a phase II randomised trial of gemcitabine- or capecitabine-based chemoradiation for locally advanced pancreatic cancer

British Journal of Cancer ◽

10.1038/bjc.2017.95 ◽

2017 ◽

Vol 116 (10) ◽

pp. 1264-1270 ◽

Author(s):

C N Hurt ◽

S Falk ◽

T Crosby ◽

A McDonald ◽

R Ray ◽

...

Keyword(s):

Pancreatic Cancer ◽

Phase Ii ◽

Randomised Trial ◽

Locally Advanced ◽

Advanced Pancreatic Cancer ◽

Locally Advanced Pancreatic Cancer ◽

Long Term Results ◽

Recurrence Patterns

Download Full-text